| 71. |
- Nilbert, Mef, et al.
(författare)
-
Viktigt att upptäcka ärftliga fall av kolorektal- och endometriecancer. Mutationer hos »HNPCC-individer» kan orsaka flera tumörsjukdomar
- 2002
-
Ingår i: Läkartidningen. - 0023-7205. ; 99:34, s. 300-3296
-
Tidskriftsartikel (refereegranskat)abstract
- Hereditary Nonpolyposis Colorectal Cancer (HNPCC) is one of our most common hereditary cancer syndromes and confers an increased risk for several tumor types, with the greatest lifetime risks being for colorectal cancer and endometrial cancer. Hereditary mutations in one of several mismatch-repair (MMR) genes cause the syndrome, and 39 such mutations, involving the genes MLH1, MSH2 and MSH6, have been been characterized in Sweden. Screening programs for HNPCC have been shown to be cost-effective and to prevent cancer. Identification of HNPCC individuals thus allows prevention of additional tumors in the patient as well as in the family.
|
|
| 72. |
- Nordgren, Daniel, et al.
(författare)
-
Studies of heat transfer and furnace temperature uniformity during combustion of oil and wood using oxygen enrichment technology
- 2011
-
Ingår i: Swedish-Finnish Flame Days 2011.
-
Konferensbidrag (övrigt vetenskapligt/konstnärligt)abstract
- In many combustion applications a switch from fossil to renewable fuels, e.g. from fueloil to wood powder, may result in a reduction of production capacity in the boiler,furnace or kiln. Oxygen enrichment of the combustion air can be used to improve thethermal efficiency of practical combustors, i.e. reduce heat losses and promote fuelsavings. In addition, oxygen enrichment can reduce NOx emissions and also facilitateCO2 scrubbing and capture processes in such systems. In this work, flame characteristicsand furnace temperature profiles during oxygen enriched combustion were studied whenoxygen was added to the combustor at different enrichment levels by the use of a lance.The experiments were carried out in a pilot-scale furnace fired with (i) wood powder and(ii) heavy fuel oil (no.5). The results show that for the wood flame, the average furnacetemperature becomes higher and the furnace temperature profile becomes more flat.Thus, compared to conventional air combustion, there are smaller differences betweennear-burner and back-end temperatures as oxygen is added to the process. For the oilflame, as oxygen was added to the process, a higher average furnace temperature wasobserved along with a distinct shift in furnace peak temperature towards the central partsof the furnace, creating a relatively strong temperature gradient towards the back-end ofthe furnace. Comparing the two flames, the furnace temperature profile of the oxygenenriched wood flame becomes more flat compared to the oxygen enriched oil flame. Thisis interpreted as an effect of differences in overall fuel reactivity, in which the oil, being aliquid fuel, ignites and burns faster than the solid fuel wood powder. The results found inthis work shows that the burner that was used, being designed for conventional aircombustion by feeding of air through the primary, secondary and tertiary air vanes, couldhandle the changes in aerodynamics caused by the reduced air flows. The general resultsfrom this work are useful for furnace and kiln applications in which a more controllableflame and process temperature is required, e.g. in a lime kiln where a fuel switch fromfossil fuels to biomass is considered.
|
|
| 73. |
|
|
| 74. |
|
|
| 75. |
- Olsson, Mats, et al.
(författare)
-
The UGT2B17 gene deletion is not associated with prostate cancer risk
- 2008
-
Ingår i: The Prostate. - : Wiley-Blackwell. - 0270-4137 .- 1097-0045. ; 68:5, s. 571-575
-
Tidskriftsartikel (refereegranskat)abstract
- BACKGROUND: Deletion polymorphism of the UDP-glucuronosyltransferase 2B17 (UGT2B17) gene has been associated with an increased prostate cancer risk in two previous independent studies. Here we determine the risk in a large-scale population-based case-control study.METHODS: Genotyping was conducted with a 5'-nuclease activity assay to distinguish those with one or two UGT2B17 gene copies (ins/del and ins/ins) from individuals homozygous for the deletion (del/del) allele.RESULTS: In contrast to previous findings, no association between the UGT2B17 deletion polymorphism and prostate cancer risk was found. Furthermore the UGT2B17 gene deletion did not affect the risk for prostate cancer specific death.CONCLUSION: The UGT2B17 deletion polymorphism does not play a major role in prostate cancer susceptibility as previously indicated.
|
|
| 76. |
- Rantalainen, Mattias, et al.
(författare)
-
Sequencing-based breast cancer diagnostics as an alternative to routine biomarkers
- 2016
-
Ingår i: Scientific Reports. - Stockholm : Karolinska Institutet, Dept of Medical Epidemiology and Biostatistics. - 2045-2322.
-
Tidskriftsartikel (refereegranskat)abstract
- Sequencing-based breast cancer diagnostics have the potential to replace routine biomarkers and provide molecular characterization that enable personalized precision medicine. Here we investigate the concordance between sequencing-based and routine diagnostic biomarkers and to what extent tumor sequencing contributes clinically actionable information. We applied DNA- and RNA-sequencing to characterize tumors from 307 breast cancer patients with replication in up to 739 patients. We developed models to predict status of routine biomarkers (ER, HER2,Ki-67, histological grade) from sequencing data. Non-routine biomarkers, including mutations in BRCA1, BRCA2 and ERBB2(HER2), and additional clinically actionable somatic alterations were also investigated. Concordance with routine diagnostic biomarkers was high for ER status (AUC = 0.95;AUC(replication) = 0.97) and HER2 status (AUC = 0.97;AUC(replication) = 0.92). The transcriptomic grade model enabled classification of histological grade 1 and histological grade 3 tumors with high accuracy (AUC = 0.98;AUC(replication) = 0.94). Clinically actionable mutations in BRCA1, BRCA2 and ERBB2(HER2) were detected in 5.5% of patients, while 53% had genomic alterations matching ongoing or concluded breast cancer studies. Sequencing-based molecular profiling can be applied as an alternative to histopathology to determine ER and HER2 status, in addition to providing improved tumor grading and clinically actionable mutations and molecular subtypes. Our results suggest that sequencing-based breast cancer diagnostics in a near future can replace routine biomarkers
|
|
| 77. |
- Reynolds, Chandra A, et al.
(författare)
-
Analysis of lipid pathway genes indicates association of sequence variation near SREBF1/TOM1L2/ATPAF2 with dementia risk.
- 2010
-
Ingår i: Human molecular genetics. - : Oxford University Press (OUP). - 1460-2083 .- 0964-6906. ; 19:10, s. 2068-2078
-
Tidskriftsartikel (refereegranskat)abstract
- We conducted dense linkage disequilibrium mapping of a series of 25 genes putatively involved in lipid metabolism in 1567 dementia cases (including 1270 with Alzheimer disease) and 2203 Swedish controls. Across a total of 448 tested genetic markers, the strongest evidence of association was as anticipated for APOE (rs429358 at p approximately 10(-72)) followed by a previously reported association of ABCA1 (rs2230805 at p approximately 10(-8)). In the present study we report two additional markers near the SREBF1 locus on chromosome 17p that were also significant after multiple testing correction (best p=3.1 x 10(-6) for marker rs3183702). There was no convincing evidence of association for remaining genes, including candidates highlighted from recent genome-wide association studies of plasma lipids (CELSR2/PSRC1/SORT1, MLXIPL, PCSK9, GALNT2, and GCKR). The associated markers near SREBF1 reside in a large linkage disequilibrium block, extending more than 400kb across 7 candidate genes. Secondary analyses of gene expression levels of candidates spanning the LD region together with an investigation of gene network context highlighted two possible susceptibility genes including ATPAF2 and TOM1L2. Several markers in strong LD (r(2)>0.7) with rs3183702 were found to be significantly associated with AD risk in recent genome-wide association studies with similar effect sizes, providing independent support of the current findings.
|
|
| 78. |
- Sahlin, Pelle, et al.
(författare)
-
Women with Saethre-Chotzen syndrome are at increased risk of breast cancer.
- 2007
-
Ingår i: Genes, chromosomes & cancer. - : Wiley. - 1045-2257 .- 1098-2264. ; 46:7, s. 656-60
-
Tidskriftsartikel (refereegranskat)abstract
- The Saethre-Chotzen syndrome is an autosomal, dominantly inherited craniosynostosis caused by mutations in the basic helix-loop-helix transcription factor gene TWIST1. This syndrome has hitherto not been associated with an increased risk of cancer. However, recent studies, using a murine breast tumor model, have shown that Twist may act as a key regulator of metastasis and that the gene is overexpressed in subsets of sporadic human breast cancers. Here, we report a novel association between the Saethre-Chotzen syndrome and breast cancer. In 15 Swedish Saethre-Chotzen families, 15 of 29 (52%) women carriers over the age of 25 had developed breast cancer. At least four patients developed breast cancer before 40 years of age, and five between 40 and 50 years of age. The observed cases with breast cancer (n = 15) are significantly higher than expected (n = 0.89), which gives a standardized incidence ratio (SIR) of 16.80 (95% CI 1.54-32.06). Our finding of a high frequency of breast cancer in women with the Saethre-Chotzen syndrome identifies breast cancer as an important and previously unrecognized symptom characteristic of this syndrome. The results strongly suggest that women carriers of this syndrome would benefit from genetic counseling and enrolment in surveillance programs including yearly mammography. Our results also indicate that the TWIST1 gene may be a novel breast cancer susceptibility gene. Additional studies are, however, necessary to reveal the mechanism by which TWIST1 may predispose to early onset breast cancer in Saethre-Chotzen patients.
|
|
| 79. |
|
|
| 80. |
|
|
